| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/27/2009 | US7482326 endothelial-monocyte activating polypeptide III (EMAP III) cDNA encoding such proteins; anticarcinogenic agent; diagnostically or therapeutically useful |
| 01/27/2009 | US7482325 Downregulation of immune response by administering B7RP-2 fusion protein |
| 01/27/2009 | US7482324 Bone morphogenic protein for identifying modulators for treatment of bone diseases |
| 01/27/2009 | US7482323 Intracellular interleukin-1 receptor antagonist and uses thereof |
| 01/27/2009 | US7482322 Plexin family-like polypeptide, and uses thereof |
| 01/27/2009 | US7482321 Extended glucagon-like peptide-1 analogs |
| 01/27/2009 | US7482320 Modulation of smooth muscle cell proliferation |
| 01/27/2009 | US7482319 delivery of enzyme, a pharmaceutical agent, a plasmid, a polynucleotide, a polypeptide, a sensor to an organism, tissue or cell by incorporting into a vault like particle such as polypeptide, linked to MVP, VPARP, a portion of VPARP, or a modified MVP, VPARP; adminstering |
| 01/27/2009 | US7482159 Snail, a new marker for tumour invasion and target protein of new antitumoral compounds |
| 01/27/2009 | US7482157 Monacolin K biosynthesis genes |
| 01/27/2009 | US7482151 Alleviating or preventing the accumulation of ammonia in a medium via microorganisms that oxidize ammonia to nitrite; bioremediation; biodegradation |
| 01/27/2009 | US7482150 Immunization against contagious and fatal hemorrhagic fever syndrome |
| 01/27/2009 | US7482147 polypeptides, proteins or fusion proteins having hydrolase enzyme activity, used for medical diagnosis and therapy |
| 01/27/2009 | US7482139 Variants of antithrombin III |
| 01/27/2009 | US7482126 Transcription factor as repressor of expression of E-cadherin; drug screening |
| 01/27/2009 | US7482117 Using presence of single nucleotide polymorphism in apopoliprotein gene sequences as diagnostic indicator of cardiovascular disorders |
| 01/27/2009 | US7482016 Immunogenic compositions comprising HIV-1 acetylated Tat polypeptides |
| 01/27/2009 | US7482015 Optimized expression of HPV 45 L1 in yeast |
| 01/27/2009 | US7482014 Administering polyoxyethylene glycol modified interferon-alpha; immunotherapy |
| 01/27/2009 | US7482013 Albumin fusion proteins |
| 01/27/2009 | US7482012 Streptococcus pyogenes polypeptides and corresponding DNA fragments |
| 01/27/2009 | US7482010 Non-anaphylactic forms of grass pollen Phl p 6 allergen and their use |
| 01/27/2009 | US7482009 Non-anaphylactic forms of grass pollen Phl p 6 allergen and their use |
| 01/27/2009 | US7482008 Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor |
| 01/27/2009 | US7482007 Methods of inhibiting angiogenesis to treat cancer with alphavbeta3-specific antibodies |
| 01/27/2009 | US7482005 Methods of treating diseases with anti-VEGF antibodies |
| 01/27/2009 | US7482003 Also for treatment of inflammatory bowel disease; humanized heavy/light chains; complementary determining regions |
| 01/27/2009 | US7482002 Method of administering and using VEGF inhibitors for the treatment of prostate cancer |
| 01/27/2009 | US7482001 Method of administering and using VEGF inhibitors for the treatment of non small cell lung cancer |
| 01/27/2009 | US7481999 Compounds and methods for modulating OB-cadherin-mediated function |
| 01/27/2009 | US7481994 Calcium biosensor polypeptides and methods of use |
| 01/27/2009 | CA2476653C Cross-linked bioactive hydrogel matrices |
| 01/27/2009 | CA2411786C A process for the preparation of polypeptides from n-carboxyanhydrides of amino acids |
| 01/27/2009 | CA2380783C Human monoclonal antibodies to prostate specific membrane antigen |
| 01/27/2009 | CA2353483C Il-1 zeta, il-1 zeta splice variants and xrec2 dnas and polypeptides |
| 01/27/2009 | CA2319206C Peptide structures and their use in diagnosis of herpes simplex virus type 2 |
| 01/27/2009 | CA2309653C Use of protein h as cytostatic agent |
| 01/27/2009 | CA2295141C Use of a fluorescent protein for detecting interaction between a target protein and its ligand |
| 01/27/2009 | CA2285040C Death domain containing receptor 5 |
| 01/27/2009 | CA2236837C Detection of mammary tumor virus-like sequences in human breast cancer |
| 01/27/2009 | CA2225278C Recombinant mva virus, and the use thereof |
| 01/27/2009 | CA2191951C Monoamine, diamide, thiol-containing metal chelating agents |
| 01/27/2009 | CA2186747C Interleukin-15 |
| 01/27/2009 | CA2179825C Method for producing protein |
| 01/27/2009 | CA2173846C Cntf family antagonists |
| 01/27/2009 | CA2135644C Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 01/27/2009 | CA2045869C Fusion proteins with immunoglobulin portions, the preparation and use thereof |
| 01/25/2009 | CA2597865A1 Compositions for therapeutic treatment of hpv related conditions and diseases |
| 01/22/2009 | WO2009012176A2 Methods and compositions for treating brain diseases |
| 01/22/2009 | WO2009012026A2 Method of patterning a substrate |
| 01/22/2009 | WO2009011828A2 Methods and compositions useful for modulating drug-induced impairment |
| 01/22/2009 | WO2009011544A2 Insulinotropic peptide derivative wherein its n-terminal amino acid is modified |
| 01/22/2009 | WO2009011477A1 Hypoxia- inducible stat5b and the use thereof for cancer treatment |
| 01/22/2009 | WO2009010957A2 Heparanase c-terminal domain, sequences derived therefrom, substances directed against said domain and uses thereof as modulators of heparanase biological activity |
| 01/22/2009 | WO2009010874A2 Preprocalcitonin antigen t epitopes |
| 01/22/2009 | WO2009010826A2 Novel genes and methods of producing carotenoids |
| 01/22/2009 | WO2009010769A1 Pharmaceutical compositions comprising nucleic acids encoding constitutively active toll-like receptors. |
| 01/22/2009 | WO2009010765A2 Lantibiotic-based compounds having antimicrobial activity |
| 01/22/2009 | WO2009010733A2 Peptide gap junction modulators |
| 01/22/2009 | WO2009010611A1 Polypeptides derived from psap protein (presenilin 1 - associated protein) capable of causing apoptosis and uses of the same |
| 01/22/2009 | WO2009010540A1 New polypeptides inducing apoptosis and uses thereof |
| 01/22/2009 | WO2009010539A2 Receptor for interleukin-6 (il-6) from macaca fascicularis |
| 01/22/2009 | WO2009010474A1 Antibody or fragment thereof recognizing avitagtm and uses thereof |
| 01/22/2009 | WO2009010460A2 Transgenic plants with increased stress tolerance and yield |
| 01/22/2009 | WO2009010428A1 Protease stabilized, pegylated insulin analogues |
| 01/22/2009 | WO2009010398A1 Stabilized prolactin receptor antagonists |
| 01/22/2009 | WO2009010270A2 Purification of pegylated polypeptides |
| 01/22/2009 | WO2009010121A1 Phosphorylation of histone h3 at threonine 11 - a novel epigenetic mark for transcriptional regulation |
| 01/22/2009 | WO2009009919A1 An escherichia coli expressing trail protein and its construction method and applications |
| 01/22/2009 | WO2009009892A1 Engineered scfv against bovine herpes virus type i |
| 01/22/2009 | WO2009009883A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | WO2009009876A1 Influenza virus-like particles (vlps) comprising hemagglutinin produced within a plant |
| 01/22/2009 | WO2008145629A3 Yield enhancement in plants by modulation of maize alfins |
| 01/22/2009 | WO2008144590A3 Long lasting modified antifusogenic peptide for preventing hiv infection |
| 01/22/2009 | WO2008144584A3 Cysteic acid derivatives of anti-viral peptides |
| 01/22/2009 | WO2008135206A3 Means and methods for providing ribulose bisphosphate-carboxylase-oxygenase with improved properties |
| 01/22/2009 | WO2008122769A3 Adenoviral vector encoding malaria antigen |
| 01/22/2009 | WO2008121830A3 Phage receptor binding proteins for antibacterial therapy and other novel uses |
| 01/22/2009 | WO2008082519A3 Screening for cd93 (c1qrp)-associated polymorphism(s) in the diagnosis, prevention and treatment of autoimmune diseases |
| 01/22/2009 | WO2008070460A9 The use of soluble e-cadherin as a novel serum marker |
| 01/22/2009 | WO2008053019A3 Method for reducing the expression of a gene in a filamentous fungal cell |
| 01/22/2009 | WO2001092300A9 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level |
| 01/22/2009 | US20090025103 Defensin polynucleotides and methods of use |
| 01/22/2009 | US20090025100 DWF12 and Mutants Thereof |
| 01/22/2009 | US20090025098 Hepatitis C receptor protein CD81 |
| 01/22/2009 | US20090025095 Method for Evaluating Compound Using Barlp and Substance for Regulating Eating and Body Weight |
| 01/22/2009 | US20090024906 Method and apparatus for data transmission using multiple transmit antenas |
| 01/22/2009 | US20090023909 Blueberry red ringspot virus, sequences, promoters, and uses thereof |
| 01/22/2009 | US20090023905 Transgenic animal model of bone mass modulation |
| 01/22/2009 | US20090023901 Degradable Clostridial Toxins |
| 01/22/2009 | US20090023899 Defatting collagen |
| 01/22/2009 | US20090023898 Methods and compositions for protein purification |
| 01/22/2009 | US20090023894 Neutralizing Antibody Against HGF |
| 01/22/2009 | US20090023893 Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis |
| 01/22/2009 | US20090023745 Substituted Pyrazolo[4,3-c]Pyridine Derivatives Active as Kinase Inhibitors |
| 01/22/2009 | US20090023707 1-{4-[4-(pyrrolidin-1-ylmethyl)-1,3-oxazol-2-yl]benzyl}-1H-benzimidazole, used for the treatment of central nervous system disorders |
| 01/22/2009 | US20090023660 Novel Hemopoietin Receptor Protein, NR12 |
| 01/22/2009 | US20090023659 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 01/22/2009 | US20090023658 Neovascularization Inhibitors Derived From HGF and Methods Involving the Same |
| 01/22/2009 | US20090023657 Catecholamine regulated protein |